• HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
Saturday, August 13, 2022
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
  • HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Cancer

Oncotarget: Modulating Tau Post-translational modifications and cytoskeletal network

Bioengineer by Bioengineer
July 12, 2021
in Cancer
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

EGCG, a green tea polyphenol, as a modulator of in vitro methylglyoxal-induced Tau glycation and its impact on reducing advanced glycation end products in neuroblastoma cells

IMAGE

Credit: Correspondence to – Subashchandrabose Chinnathambi – [email protected]

Oncotarget published “Epigallocatechin-3-gallate modulates Tau Post-translational modifications and cytoskeletal network” which reported that the chemical modulators of Tau PTMs, such as kinase inhibitors and antibody-based therapeutics, have been developed, but natural compounds, as modulators of Tau PTMs are not much explored.

These authors applied biophysical and biochemical techniques like fluorescence kinetics, oligomerization analysis and transmission electron microscopy to investigate the impact of EGCG on Tau glycation in vitro.

EGCG inhibited methyl glyoxal -induced Tau glycation in vitro.

EGCG potently inhibited MG-induced advanced glycation endproducts formation in neuroblastoma cells as well modulated the localization of AT100 phosphorylated Tau in the cells.

They report EGCG, a green tea polyphenol, as a modulator of in vitro methylglyoxal-induced Tau glycation and its impact on reducing advanced glycation end products in neuroblastoma cells.

EGCG, a green tea polyphenol, as a modulator of in vitro methylglyoxal-induced Tau glycation and its impact on reducing advanced glycation end products in neuroblastoma cells.

Dr. Subashchandrabose Chinnathambi from The CSIR-National Chemical Laboratory as well as The Academy of Scientific and Innovative Research said, “Tau is a microtubule-associated protein, which aids in neuronal functioning [1, 2] and Tau neurofibrillary tangles is one of the important characteristic pathology in AD.“

The clearance of hyperphosphorylated Tau is decreased by PTMs like glycation, nitration and polyamination whereas glycosylation and dephosphorylation prevents Tau hyperphosphorylation.

Glycation, unlike phosphorylation, is a non-enzymatic PTM, occurring between reducing sugars and protein, lipids etc. Glycation is triggered in presence of high blood sugar levels due to their metabolism via polyol pathway, which converts sugars into highly reactive intermediates like methyl glyoxal, gloxal etc. Glycation involves multistep reactions including complex re-arrangements forming advanced glycation end products .

Moreover, Tau glycation is modulated in an isoform-dependent manner and glycation along with phosphorylation increases the aggregation propensity of full-length Tau.

In this study, they demonstrate the effect of EGCG in inhibiting Tau glycation in vitro and global glycation in the neuroblastoma cells.

The Chinnathambi Research Team concluded in their Oncotarget“> Research Output that similar studies have reported decrease in MG-induced AGEs formation in neuro2a by AG.

The decrease in AGEs and ROS by EGCG has already been shown by previous studies via Nrf2 -dependent pathways in various cell types.

The exact mechanism of inhibiting AGEs formation in mouse neuroblastoma cells is unclear but it might be due to the quenching of carbonyls formed during glycation by EGCG.

EGCG was found to reduce the glycation of cytoskeletal elements like actin and tubulin.

Reduced glycation was accompanied with resumed tubulin assembly and enhanced actin extensions thus improving neuronal structural integrity.

###

DOI – https://doi.org/10.18632/oncotarget.27963

Full text – https://www.oncotarget.com/article/27963/text/

Correspondence to – Subashchandrabose Chinnathambi – [email protected]

Keywords –
Alzheimer’s disease,
Tau protein,
Tau PTMs,
Tau glycation,
Tau glycation inhibition

About Oncotarget

Oncotarget is a bi-weekly, peer-reviewed, open access biomedical journal covering research on all aspects of oncology.

To learn more about Oncotarget, please visit https://www.oncotarget.com or connect with:

SoundCloud – https://soundcloud.com/oncotarget
Facebook – Oncotarget/”>https://www.facebook.com/Oncotarget/
Twitter – https://twitter.com/oncotarget
LinkedIn – https://www.linkedin.com/company/oncotarget
Pinterest – https://www.pinterest.com/oncotarget/
Reddit – Oncotarget/”>https://www.reddit.com/user/Oncotarget/

Oncotarget is published by Impact Journals, LLC please visit https://www.ImpactJournals.com or connect with @ImpactJrnls

Media Contact

[email protected]
18009220957×105

Copyright © 2021 Impact Journals, LLC
Impact Journals is a registered trademark of Impact Journals, LLC

Media Contact
Ryan James Jessup
[email protected]

Original Source

https://www.oncotarget.com/news/pr/modulating-tau-post-translational-modifications-and-cytoskeletal-network/

Related Journal Article

http://dx.doi.org/10.18632/oncotarget.27963

Tags: BiologycancerCarcinogensEducationMedicine/HealthPolicy/Ethics
Share12Tweet8Share2ShareShareShare2

Related Posts

Mike Crosby

Crosby elected Vice Chair of Patient Advocacy Advisory Board for the Society of Nuclear Medicine and Molecular Imaging

August 12, 2022
Cover, JNCCN August 2022

There’s a better way to detect high-risk medications in older adults with cancer according to new study in JNCCN

August 10, 2022

New UCI-led research reveals the circadian clock influences cell growth, metabolism and tumor progression

August 10, 2022

Declines in opioid prescriptions for U.S. patients with cancer and non-cancer pain, study shows

August 10, 2022
Please login to join discussion

POPULAR NEWS

  • Picture of the horse specimen.

    Ancient DNA clarifies the early history of American colonial horses

    56 shares
    Share 22 Tweet 14
  • Fatigue, headache among top lingering symptoms months after COVID

    40 shares
    Share 16 Tweet 10
  • Ill-fated ‘Into the Wild’ adventurer was victim of unfortunate timing, Oregon State study suggests

    39 shares
    Share 16 Tweet 10
  • Skin: An additional tool for the versatile elephant trunk

    38 shares
    Share 15 Tweet 10

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Tags

Zoology/Veterinary ScienceVirologyUniversity of WashingtonVirusUrbanizationUrogenital SystemWeaponryVehiclesWeather/StormsVaccineVaccinesViolence/Criminals

Recent Posts

  • UTA researcher explores integration and power electronic regulation of batteries for Navy
  • Bug eyes and bat sonar: UCLA bioengineers turn to animal kingdom for creation of bionic super 3D cameras
  • Overcoming a major manufacturing constraint
  • Snyder Institute researchers discover new approach to healing skin infections and wounds
  • Contact Us

© 2019 Bioengineer.org - Biotechnology news by Science Magazine - Scienmag.

No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

© 2019 Bioengineer.org - Biotechnology news by Science Magazine - Scienmag.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In